Bogle Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,078,345
| Closed | -$9.06M | – | 299 |
|
|
2017
Q1 | $9.06M | Buy |
+1,078,345
| New | +$9.06M | 0.63% | 71 |
|
|
2015
Q4 | – | Sell |
-490,747
| Closed | -$5.59M | – | 378 |
|
|
2015
Q3 | $5.59M | Buy |
+490,747
| New | +$5.59M | 0.4% | 94 |
|
|
2014
Q3 | – | Sell |
-626,013
| Closed | -$7.98M | – | 351 |
|
|
2014
Q2 | $7.98M | Buy |
+626,013
| New | +$7.98M | 0.53% | 79 |
|
|
2013
Q4 | – | Sell |
-386,089
| Closed | -$2.81M | – | 302 |
|
|
2013
Q3 | $2.81M | Buy |
+386,089
| New | +$2.81M | 0.28% | 122 |
|